As a biomarker for bladder cancer, fucosylated-glycoisoform of integrin alpha-3 (ITGA3) from the urine of bladder cancer patients was utilized for bladder cancer diagnosis. This evidence concerns the gene ITGA3 and urinary bladder carcinoma.